Immutep (IMMP) Total Current Liabilities (2011 - 2025)
Immutep (IMMP) posted Total Current Liabilities of $30.9 million for Q4 2025, up 277.75% on a QoQ basis from $8.2 million in Q2 2025, and up 412.38% year-over-year from $6.0 million in Q4 2024.
Immutep (IMMP) Total Current Liabilities (2011 - 2025) Analysis & Trends
Immutep's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $30.9 million for Q4 2025.
- Quarterly Total Current Liabilities rose 412.38% year-over-year to $30.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.9 million (up 412.38% YoY) and the FY2025 annual result came in at $8.2 million, up 18.24% from the prior year.
- Total Current Liabilities was $30.9 million for Q4 2025 at Immutep, up from $8.2 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $30.9 million in Q4 2025 and bottomed at $4.1 million in Q2 2021.
- A 5-year average of $8.3 million and a median of $5.9 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities slipped 22.49% — and 2025, when it soared 412.38%.
- Immutep's Total Current Liabilities stood at $5.7 million in 2021, then fell by 3.73% to $5.5 million in 2022, then slipped by 22.49% to $4.3 million in 2023, then soared by 41.14% to $6.0 million in 2024, then surged by 412.38% to $30.9 million in 2025.
- Business Quant data shows IMMP's Total Current Liabilities at $30.9 million in Q4 2025, $8.2 million in Q2 2025, and $6.0 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Immutep | 567.77 Mn | 567.77 Mn | - | 30.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.87 Mn |
| Jun 30, 2025 | 8.17 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Jun 30, 2024 | 6.91 Mn |
| Dec 31, 2023 | 4.27 Mn |
| Jun 30, 2023 | 6.53 Mn |
| Dec 31, 2022 | 5.51 Mn |
| Jun 30, 2022 | 4.59 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Jun 30, 2021 | 4.11 Mn |
| Dec 31, 2020 | 3.81 Mn |
| Jun 30, 2020 | 2.20 Mn |
| Dec 31, 2019 | 2.71 Mn |
| Jun 30, 2019 | 3.71 Mn |
| Dec 31, 2018 | 2.96 Mn |
| Jun 30, 2018 | 2.92 Mn |
| Jun 30, 2017 | 1.98 Mn |
| Mar 31, 2017 | 951,285.54 |
| Jun 30, 2016 | 1.10 Mn |
| Jun 30, 2015 | 3.40 Mn |